Annual Current Liabilities
$1.20 B
+$173.00 M+16.92%
31 December 2023
Summary:
Edwards Lifesciences annual total current liabilities is currently $1.20 billion, with the most recent change of +$173.00 million (+16.92%) on 31 December 2023. During the last 3 years, it has risen by +$163.10 million (+15.80%). EW annual current liabilities is now -15.82% below its all-time high of $1.42 billion, reached on 31 December 2017.EW Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$1.94 B
+$727.10 M+59.75%
30 September 2024
Summary:
Edwards Lifesciences quarterly total current liabilities is currently $1.94 billion, with the most recent change of +$727.10 million (+59.75%) on 30 September 2024. Over the past year, it has increased by +$748.70 million (+62.63%). EW quarterly current liabilities is now at all-time high.EW Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EW Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +62.6% |
| 3 y3 years | +15.8% | +88.3% |
| 5 y5 years | +32.5% | +115.4% |
EW Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +16.9% | at high | +111.8% |
| 5 y | 5 years | at high | +33.7% | at high | +160.3% |
| alltime | all time | -15.8% | +666.3% | at high | +1146.2% |
Edwards Lifesciences Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.94 B(+59.7%) |
| June 2024 | - | $1.22 B(+9.6%) |
| Mar 2024 | - | $1.11 B(-7.1%) |
| Dec 2023 | $1.20 B(+16.9%) | $1.20 B(-3.5%) |
| Sept 2023 | - | $1.24 B(+7.1%) |
| June 2023 | - | $1.16 B(+7.0%) |
| Mar 2023 | - | $1.08 B(+5.8%) |
| Dec 2022 | $1.02 B(-1.0%) | $1.02 B(+11.4%) |
| Sept 2022 | - | $917.90 M(-5.3%) |
| June 2022 | - | $969.10 M(+2.0%) |
| Mar 2022 | - | $949.90 M(-8.0%) |
| Dec 2021 | $1.03 B(+15.5%) | $1.03 B(+6.8%) |
| Sept 2021 | - | $966.50 M(+9.1%) |
| June 2021 | - | $886.20 M(+10.9%) |
| Mar 2021 | - | $799.00 M(-10.6%) |
| Dec 2020 | $893.90 M(-0.9%) | $893.90 M(+5.6%) |
| Sept 2020 | - | $846.30 M(-3.1%) |
| June 2020 | - | $873.20 M(+16.9%) |
| Mar 2020 | - | $746.90 M(-17.2%) |
| Dec 2019 | $902.40 M(+2.9%) | $902.40 M(+16.3%) |
| Sept 2019 | - | $775.80 M(+11.3%) |
| June 2019 | - | $697.00 M(+7.8%) |
| Mar 2019 | - | $646.50 M(-26.2%) |
| Dec 2018 | $876.60 M(-38.3%) | $876.60 M(-30.5%) |
| Sept 2018 | - | $1.26 B(+6.6%) |
| June 2018 | - | $1.18 B(-10.0%) |
| Mar 2018 | - | $1.31 B(-7.4%) |
| Dec 2017 | $1.42 B(+166.7%) | $1.42 B(+93.1%) |
| Sept 2017 | - | $735.20 M(+30.7%) |
| June 2017 | - | $562.50 M(-3.8%) |
| Mar 2017 | - | $584.80 M(+9.8%) |
| Dec 2016 | $532.50 M(+11.8%) | $532.50 M(-0.1%) |
| Sept 2016 | - | $532.80 M(+11.4%) |
| June 2016 | - | $478.20 M(+4.3%) |
| Mar 2016 | - | $458.30 M(-3.8%) |
| Dec 2015 | $476.20 M(+11.8%) | $476.20 M(-10.6%) |
| Sept 2015 | - | $532.50 M(+19.6%) |
| June 2015 | - | $445.20 M(+9.8%) |
| Mar 2015 | - | $405.30 M(-4.9%) |
| Dec 2014 | $426.10 M(+23.3%) | $426.10 M(-0.4%) |
| Sept 2014 | - | $427.80 M(-20.9%) |
| June 2014 | - | $540.50 M(+51.7%) |
| Mar 2014 | - | $356.20 M(+3.1%) |
| Dec 2013 | $345.60 M(-0.5%) | $345.60 M(+3.1%) |
| Sept 2013 | - | $335.10 M(+6.7%) |
| June 2013 | - | $314.20 M(+4.6%) |
| Mar 2013 | - | $300.40 M(-13.5%) |
| Dec 2012 | $347.40 M | $347.40 M(+16.3%) |
| Sept 2012 | - | $298.60 M(+5.0%) |
| June 2012 | - | $284.30 M(+7.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $265.20 M(-20.9%) |
| Dec 2011 | $335.20 M(-0.8%) | $335.20 M(+11.0%) |
| Sept 2011 | - | $302.00 M(-3.6%) |
| June 2011 | - | $313.30 M(-29.6%) |
| Mar 2011 | - | $445.20 M(+31.8%) |
| Dec 2010 | $337.80 M(+16.3%) | $337.80 M(-11.6%) |
| Sept 2010 | - | $382.20 M(+54.3%) |
| June 2010 | - | $247.70 M(+2.3%) |
| Mar 2010 | - | $242.20 M(-16.6%) |
| Dec 2009 | $290.50 M(+12.4%) | $290.50 M(-2.0%) |
| Sept 2009 | - | $296.30 M(+20.9%) |
| June 2009 | - | $245.10 M(+22.4%) |
| Mar 2009 | - | $200.20 M(-22.6%) |
| Dec 2008 | $258.50 M(-31.1%) | $258.50 M(+12.4%) |
| Sept 2008 | - | $229.90 M(+1.5%) |
| June 2008 | - | $226.60 M(-42.1%) |
| Mar 2008 | - | $391.60 M(+4.3%) |
| Dec 2007 | $375.40 M(+66.0%) | $375.40 M(+7.6%) |
| Sept 2007 | - | $348.80 M(+7.8%) |
| June 2007 | - | $323.60 M(+80.4%) |
| Mar 2007 | - | $179.40 M(-20.7%) |
| Dec 2006 | $226.20 M(+16.5%) | $226.20 M(-0.6%) |
| Sept 2006 | - | $227.50 M(+0.4%) |
| June 2006 | - | $226.50 M(+15.0%) |
| Mar 2006 | - | $197.00 M(+1.4%) |
| Dec 2005 | $194.20 M(-0.6%) | $194.20 M(-5.1%) |
| Sept 2005 | - | $204.60 M(+7.5%) |
| June 2005 | - | $190.40 M(+7.9%) |
| Mar 2005 | - | $176.40 M(-9.7%) |
| Dec 2004 | $195.40 M(+16.9%) | $195.40 M(+14.7%) |
| Sept 2004 | - | $170.30 M(+9.2%) |
| June 2004 | - | $156.00 M(-0.3%) |
| Mar 2004 | - | $156.40 M(-6.5%) |
| Dec 2003 | $167.20 M(-5.7%) | $167.20 M(-2.8%) |
| Sept 2003 | - | $172.00 M(-7.6%) |
| June 2003 | - | $186.10 M(-1.8%) |
| Mar 2003 | - | $189.60 M(+6.9%) |
| Dec 2002 | $177.30 M(-4.0%) | $177.30 M(+1.3%) |
| Sept 2002 | - | $175.00 M(-6.0%) |
| June 2002 | - | $186.10 M(+10.9%) |
| Mar 2002 | - | $167.80 M(-9.1%) |
| Dec 2001 | $184.60 M(-22.4%) | $184.60 M(+17.3%) |
| Sept 2001 | - | $157.40 M(-20.9%) |
| June 2001 | - | $199.10 M(-13.0%) |
| Mar 2001 | - | $228.90 M(-3.8%) |
| Dec 2000 | $238.00 M(+52.6%) | $238.00 M(-14.2%) |
| Sept 2000 | - | $277.40 M(-16.2%) |
| June 2000 | - | $331.00 M(-0.3%) |
| Mar 2000 | - | $332.00 M |
| Dec 1999 | $156.00 M | - |
FAQ
- What is Edwards Lifesciences annual total current liabilities?
- What is the all time high annual current liabilities for Edwards Lifesciences?
- What is Edwards Lifesciences quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Edwards Lifesciences?
- What is Edwards Lifesciences quarterly current liabilities year-on-year change?
What is Edwards Lifesciences annual total current liabilities?
The current annual current liabilities of EW is $1.20 B
What is the all time high annual current liabilities for Edwards Lifesciences?
Edwards Lifesciences all-time high annual total current liabilities is $1.42 B
What is Edwards Lifesciences quarterly total current liabilities?
The current quarterly current liabilities of EW is $1.94 B
What is the all time high quarterly current liabilities for Edwards Lifesciences?
Edwards Lifesciences all-time high quarterly total current liabilities is $1.94 B
What is Edwards Lifesciences quarterly current liabilities year-on-year change?
Over the past year, EW quarterly total current liabilities has changed by +$748.70 M (+62.63%)